Oral Presentations
Workshop 4. New insights from inflammation and immunology
WS04.2 Improvement in inflammatory biomarkers in patients (pts) with cystic fibrosis (CF) homozygous for the F508del-CFTR mutation treated with lumacaftor (LUM) and ivacaftor (IVA)

https://doi.org/10.1016/S1569-1993(16)30079-0Get rights and content
Under an Elsevier user license
open archive

Cited by (0)